tiprankstipranks
Lyra implements layoff of 75% of workforce, to evaluate strategic options
PremiumThe FlyLyra implements layoff of 75% of workforce, to evaluate strategic options
6M ago
Lyra Therapeutics trading halted, news pending
Premium
The Fly
Lyra Therapeutics trading halted, news pending
6M ago
Target upgraded, CVS downgraded: Wall Street’s top analyst calls
Premium
The Fly
Target upgraded, CVS downgraded: Wall Street’s top analyst calls
7M ago
Lyra Therapeutics downgraded to Neutral from Buy at BTIG
PremiumThe FlyLyra Therapeutics downgraded to Neutral from Buy at BTIG
7M ago
Lyra Therapeutics downgraded to Market Perform from Outperform at William Blair
Premium
The Fly
Lyra Therapeutics downgraded to Market Perform from Outperform at William Blair
7M ago
Lyra announces Phase 3 ENLIGHTEN 1 trial did not meet primary endpoint
Premium
The Fly
Lyra announces Phase 3 ENLIGHTEN 1 trial did not meet primary endpoint
7M ago
Lyra Therapeutics management to meet with Cantor Fitzgerald
PremiumThe FlyLyra Therapeutics management to meet with Cantor Fitzgerald
7M ago
Lyra Therapeutics price target lowered to $11 from $12 at BofA
Premium
The Fly
Lyra Therapeutics price target lowered to $11 from $12 at BofA
8M ago
Lyra Therapeutics files $300M mixed securities shelf
Premium
The Fly
Lyra Therapeutics files $300M mixed securities shelf
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100